Propanc Biopharma issues $33K convertible note to GS Capital Partners for working capital

Propanc Biopharma, Inc.

Convertible promissory note with $33,000 principal, purchased at $30,000 (original issue discount of $3,000).
Conversion price initially $6.00/share, drops to $3.00 if stock trades below $5.00 for 5 consecutive days.
Note matures Nov 11, 2025, bears 8% interest; prepayment allowed at 110%-125% premiums within first 180 days.
Proceeds from the private placement will be used for general working capital purposes.
Issued to GS Capital Partners, LLC in reliance on Regulation D exemption under Section 4(a)(2).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.